Upcoming Policies effective September 7, 2026
Blue Cross Minnesota has revised spinal cord stimulation (SCS) and dorsal root ganglion (DRG) stimulation coverage policy effective September 7, 2026, establishing stricter medical necessity criteria for trial and permanent implants, including mandatory 6-month conservative management, psychological evaluation, and 6-week smoking cessation requirements. A new policy classifies implantable knee shock absorbers as experimental/investigative. The policy on Psychological and Neuropsychological Testing (X-45) has been inactivated.